Investigating the involvement of the ADAM17/iRhom2 pathway in the development of cognitive impairment related to neuroinflammation has significant potential for the field of neuroscience, as it may offer insights into the underlying mechanisms of neurodegenerative diseases such as AD, PD, and multiple sclerosis. Here, ADAM17 is linked to Alzheimer disease.